PCBL Chemical Limited has submitted its monitoring agency report for the quarter ended December 31, 2025, in compliance with SEBI regulations regarding its preferential issue of warrants convertible into equity shares.

Regulatory Compliance and Report Submission

Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company filed the monitoring agency report issued by CRISIL Ratings Limited. The report covers the utilization of proceeds from the preferential issue of warrants for the quarter ended December 31, 2025.

Issue Details and Structure

The preferential issue was conducted during May 06-07, 2024, with the following parameters:

Fund Utilization and Object-wise Allocation

The proceeds are allocated across three main objects with their respective utilization status:

No proceeds were utilized for any of the stated objects during the reported quarter.

Monitoring Agency Findings

CRISIL Ratings Limited, serving as the monitoring agency, reported the following key findings:

• No deviation from the objects disclosed in the offer document
• No material deviations observed over earlier monitoring agency reports
• All utilization remains as per disclosures in the offer document
• No unfavorable events affecting the viability of the stated objects

Deployment of Unutilized Proceeds

The company has deployed the unutilized amount of Rs 336,00,00,000.00 in Bajaj Mutual Fund (Folio: 70112304151), which generated earnings of Rs 3,48,590.45 during the quarter. The market value of this investment stood at Rs 336,03,48,590.45 as of December 31, 2025.

Warrant Conversion Progress

As noted in the report, the company initially received Rs 112,00,00,000.00 (25% of total issue size) by September 30, 2024. During the reported quarter, warrant holders converted warrants worth Rs 336,00,00,000.00 into equity shares, bringing the total received amount to the complete issue size of Rs 448,00,00,000.00.

The monitoring agency confirmed that the company maintains compliance with all regulatory requirements and continues to utilize the proceeds in accordance with the stated objects of the preferential issue.

PCBL Chemical Limited has released its unaudited financial results for the quarter and nine months ended December 31, 2025, revealing a challenging performance amid market conditions. The chemical company, formerly known as PCBL Limited, reported mixed results across its standalone and consolidated operations.

Standalone Financial Performance

The company's standalone operations showed a decline in key financial metrics for the third quarter. Total income from operations decreased to ₹1,292.12 crores in Q3 FY26 from ₹1,437.97 crores in the corresponding quarter of the previous year.

Nine-Month Performance Review

For the nine-month period ended December 31, 2025, the standalone business generated total income of ₹4,236.88 crores. Net profit after tax for the nine-month period stood at ₹188.80 crores, while total comprehensive income reached ₹175.61 crores.

Consolidated Results Analysis

The consolidated financial results presented an even more challenging picture. Total income from operations for Q3 FY26 was ₹1,861.70 crores compared to ₹2,021.09 crores in Q3 FY25.

Capital Structure and Financial Position

The company maintained its paid-up equity share capital at ₹39.35 crores, with shares having a face value of ₹1 each. The net worth on a standalone basis stood at ₹3,645.13 crores, while the consolidated net worth was ₹3,548.38 crores.

Key financial ratios showed the debt-equity ratio at 0.82 for standalone operations and 1.39 for consolidated operations. The debt service coverage ratio was 0.98 for standalone and 0.87 for consolidated operations.

Regulatory Compliance

The results were filed under Regulations 33 and 52 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The complete financial results are available on the company's website and stock exchange platforms for detailed analysis by investors and stakeholders.